Vyne Therapeutics

VYNE • NASDAQ • Stock Fundamentals

Vyne Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO David T. Domzalski, with a market cap of $22.2M.

Market Cap$22.2M

Employees10.0

CEODavid T. Domzalski

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 15, 2026 · 0 months 30 days agoQ1 2026

Next EarningsAug 13, 2026 · in 2 monthsBefore Market Open · Q2 2026

Financials

Based on Q1 2026 filing

Common questions about Vyne Therapeutics

Vyne Therapeutics (VYNE) has a market capitalization of $22.2M and trades on NASDAQ.

Vyne Therapeutics has approximately 10 employees.